United States · FDA National Drug Code directory
Carisoprodol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51525-5901_8c92753a-4b60-4ecf-b411-d66665ae493e
- Product NDC
- 51525-5901
- Form
- TABLET
- Composition / generic term
- carisoprodol
- Labeler
- Mylan Pharmaceuticals Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20161001
- Source listing expiry
- 20261231
Source-listed ingredients
- CARISOPRODOL — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (51525-5901-1) · 51525-5901-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →